Fidelity Disrupt Medicin ETFFMEDETF
13F holders, Q3 2024 (September 30)7holders −1
0new positions
1sold out
$26.29avg. 13F price*
At the end of Q3 2024, 7 institutions reported holding Fidelity Disrupt Medicin ETF (FMED) in their 13F filings, down 1 from Q2 2024. 0 opened new positions and 1 sold out. The largest holders were FMR LLC ($17.4M), Wealth Enhancement Advisory Services, LLC ($14.2M) and Jane Street Group, LLC ($1.6M).
- Company
- Fidelity Disrupt Medicin ETF
- CUSIP
- 316092147
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $1K |
All 13F filers, Q2 2024 → Q3 2024: 60,782 shares bought and 66,275 shares sold, net −5,493 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 7 holders
| FMR LLC | 0.00% | Reduce -9.1% | 663,600 | $17.4M |
| Wealth Enhancement Advisory Services, LLC | 0.03% | Add +3.7% | 539,827 | $14.2M |
| Jane Street Group, LLC | 0.00% | Add +200.4% | 61,342 | $1.6M |
| UBS Group AG | 0.00% | Add +2687.0% | 641 | $17K |
| Tower Research Capital LLC (TRC) | 0.00% | No change | 162 | $4K |
| Central Pacific Bank - Trust Division | 0.00% | No change | 97 | $3K |
| Glen Eagle Advisors, LLC | 0.00% | No change | 90 | $2K |
"% of holder's portfolio" is FMED's weight in each manager's 13F, not the share of Fidelity Disrupt Medicin ETF the manager owns.